SALPIX Drug Patent Profile
Which patents cover Salpix, and what generic alternatives are available?
Salpix is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in SALPIX is acetrizoate sodium. There is one drug master file entry for this compound. Additional details are available on the acetrizoate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SALPIX?
- What are the global sales for SALPIX?
- What is Average Wholesale Price for SALPIX?
Summary for SALPIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 106 |
| DailyMed Link: | SALPIX at DailyMed |
US Patents and Regulatory Information for SALPIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | SALPIX | acetrizoate sodium | SOLUTION;INTRAUTERINE | 009008-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
